5-6 Jun 2023

Session Information

6-Jun, 14:00 - 14:30

Understanding CBD and the Market for Sleep

Theatre 2

The recent rescheduling of CBD to a pharmacist only medication will open up the market and access for consumers to be able to buy alternative natural products for the treatment of some chronic conditions. While not available now there are a number of clinical trials taking place and a number of companies in the race to get the first product to market. The Oz Medicann Group is leading the challenge with a unique formulation for clinical insomnia. Founder John Leith hosts a panel of prominent complementary medicine researchers and sleep experts to talk about the changing regulations and the interaction of CBD on sleep related disorders.

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now